Diurnal (DNL) - Martin Whitaker, CEO 00:00:00

Share On Facebook Share On Twitter

Diurnal Group (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.

Recent Videos